Stoke Therapeutics, Inc.STOKNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank75
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-14.15M
↑ 75% vs avg
Percentile
P75
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-57.08M
Historical baseline
PeriodValueYoY Change
TTM$-14.15M+85.7%
2024$-99.19M+11.7%
2023$-112.30M-9.2%
2022$-102.81M-20.8%
2021$-85.09M-69.1%
2020$-50.32M-57.9%
2019$-31.88M-153.6%
2018$-12.57M-131.0%
2017$-5.44M-